Diabetes News

The FDA approved Jardiance 10 mg tablets to lower the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death and hospitalization in adults with chronic kidney disease at risk of progression, a press release noted.

Incidence rates for both type 1 and type 2 diabetes diagnoses increased among children and adolescents during the COVID-19 pandemic compared with 2016 to 2019, according to study findings published in JAMA Network Open.

Providers should focus more on using pharmacotherapies in addition to lifestyle intervention to prevent progression from prediabetes to type 2 diabetes, according to two researchers.

In a new clinical report, the AAP recommended against low- and very low-carbohydrate diets for children and adolescents with type 1 diabetes, “except under close diabetes care team supervision utilizing safety guidelines.”

Diagnostic testing for hypertension, diabetes and hypercholesterolemia remains low globally, driven by substantial shares of low- and middle-income populations who are not tested despite meeting WHO criteria.

Physical activity during the morning and afternoon, but not during the evening, is associated with a lower risk for developing type 2 diabetes, according to findings published in Diabetologia.

Women who have a higher thyroid-stimulating hormone level early in pregnancy may have an increased risk for developing gestational diabetes, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

Women with a history of gestational diabetes had a greater risk for subsequent mortality over 30 years compared with women who have been pregnant without gestational diabetes history, according to cohort study results published in JAMA Internal Medicine.

With reports of dramatic weight loss achieved using a new generation of diabetes drugs — one FDA approved for weight loss and another with a decision expected this fall — more adults are seeking medical therapy for obesity.

Most people with type 1 diabetes using an insulin-only bionic pancreas said the device provided more benefits than burdens and stated they would recommend the device, according to findings published in Diabetes Technology & Therapeutics.